1.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
by Schröder, Fritz H, Prof
The Lancet (British edition), 2014, Vol.384 (9959), p.2027-2035
2.
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
by Ström, Peter
The lancet oncology, 2020-02, Vol.21 (2), p.222-232
3.
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
by Hugosson, Jonas, Prof
The lancet oncology, 2010, Vol.11 (8), p.725-732
4.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673
5.
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
by Widmark, Anders, MD
The Lancet (British edition), 2009, Vol.373 (9660), p.301-308
6.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661
7.
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
by Fellström, Bengt C, Prof
The Lancet (British edition), 2017, Vol.389 (10084), p.2117-2127
8.
Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden
by Mohammad, Aladdin J
Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.993-997
9.
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
by Group, Sharp Collaborative
The American heart journal, 2010, Vol.160 (5), p.785-794.e10
10.
Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children
by Björk, Jonas
Pediatric nephrology (Berlin, West), 2019-06-01, Vol.34 (6), p.1087-1098
11.
Kidney Hypoxia, Attributable to Increased Oxygen Consumption, Induces Nephropathy Independently of Hyperglycemia and Oxidative Stress
by Friederich-Persson, Malou
Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.914-919
12.
Trans-ethnic Fine Mapping Highlights Kidney-Function Genes Linked to Salt Sensitivity
by Mahajan, Anubha
American journal of human genetics, 2016-09-01, Vol.99 (3), p.636-646
13.
Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10‐year population‐based study
by Nilsson, E.
Alimentary pharmacology & therapeutics, 2016-06, Vol.43 (12), p.1330-1339
14.
The learning curve for laparoscopic radical prostatectomy: an international multicenter study
by Winfield, Howard N
Journal of endourology, 2011-06-01, Vol.25 (6), p.898
15.
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort
by Coppo, Rosanna
Pediatric nephrology (Berlin, West), 2016-08-25, Vol.32 (1), p.139-150
16.
The drama of prostate cancer diagnostics
by Bratt, Ola
The lancet oncology, 2017, Vol.18 (3), p.e132-e132
17.
Body mass index and weight change in men with prostate cancer: progression and mortality
by Bonn, Stephanie E
Cancer causes & control, 2014-08-01, Vol.25 (8), p.933-943
18.
Prostate cancer screening in Europe – Authors' reply
by Schröder, Fritz
The Lancet (British edition), 2015, Vol.385 (9977), p.1507-1508
19.
Towards “next-generation” prostate cancer screening
by Lamb, Alastair D
The lancet oncology, 2015, Vol.16 (16), p.1579-1580
20.
Urinary tract infection in infants: the significance of low bacterial count
by Swerkersson, Svante
Pediatric nephrology (Berlin, West), 2015-09-10, Vol.31 (2), p.239-245
